A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...
In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
The average life expectancy in the Big Apple last year soared to its highest level ever: 83.2 years — a milestone that wasn’t expected to be reached till 2030, according to preliminary city data. The ...
AFTER GETTING VACCINATED. PERRY RUSSOM, ABC NEWS, WASHINGTON. NEW HAMPSHIRE RANKS 10TH IN THE COUNTRY IN LIFE EXPECTANCY. A NEW REPORT FROM THE CDC SHOWS THE AVERAGE LIFE EXPECTANCY IN THE STATE IS ...
They call New York City residents "hard" for a reason. But we're getting more time to shake it off. Stats released by the NYC Health Department Tuesday show citywide life expectancy at birth rose to ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.
SAN FRANCISCO — Scott Adams, the cartoonist who created the comic strip “Dilbert,” gave fans a new and serious update about his health this week as he continues fighting advanced prostate cancer.
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results